MedTrace Logo

In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA

NCT04612036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-11-29

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.

Conditions

Interventions

DEVICE

Journey II Bi-Cruciate Stabilized TKA

Total Knee Arthroplasty System

DEVICE

Journey II Cruciate Retaining TKA

Total Knee Arthroplasty System

DEVICE

Journey II Bi-Cruciate Retaining TKA

Total Knee Arthroplasty System

Sponsors & Collaborators

  • The University of Tennessee, Knoxville

    lead OTHER

Principal Investigators

  • Michael LaCour, PhD · The University of Tennessee

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2022-05-16
Completion
2022-05-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612036 on ClinicalTrials.gov